Suppr超能文献

用于测量可螯合体内铁的去铁胺差异试验。

DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.

作者信息

FIELDING J

出版信息

J Clin Pathol. 1965 Jan;18(1):88-97. doi: 10.1136/jcp.18.1.88.

Abstract

The differential ferrioxamine test is a simple method for the measurement of chelation of body iron by desferrioxamine. A single six-hour specimen of urine is obtained after intravenous Desferal, accompanied by (59)Fe-ferrioxamine. Two values are measured: F(d), the excretion of ferrioxamine derived from body iron by chelation, and F(ex), the proportion of ferrioxamine excreted from a known intravenous dose. The data enables F(v), chelation of iron in vivo, to be calculated by simple proportion. Desferrioxamine chelation proceeds for about half an hour after injection. The results in normal subjects, in cases with known high iron stores, and in cases of iron-deficiency anaemia are described. High, normal, and low body iron states have been differentiated. F(v) values in the higher ranges obtained in iron-storage diseases and in haemolytic states are differentiated by the pattern of excretion, high F(d) values and low F(ex) values respectively. IT IS SUGGESTED THAT THERE ARE TWO MAIN SOURCES OF CHELATABLE BODY IRON: as ferritin-haemosiderin and as iron newly released from haem in a more readily chelatable form. The significance of variable chelation susceptibility in iron metabolism is briefly discussed. It is suggested that variable chelatability of different sources of body iron may explain the preferential utilization of iron released from red cells or absorbed from the intestine, rather than storage iron, in the biosynthesis of haem.

摘要

去铁胺差异试验是一种测定去铁胺对体内铁螯合作用的简单方法。静脉注射去铁胺(Desferal)并同时注射(59)Fe-去铁胺后,采集一份六小时的单次尿样。测量两个值:F(d),即通过螯合作用从体内铁衍生而来的去铁胺排泄量;F(ex),即从已知静脉剂量中排泄出的去铁胺比例。这些数据可通过简单比例计算出体内铁的螯合量F(v)。注射后去铁胺螯合作用持续约半小时。文中描述了正常受试者、已知铁储存量高的病例以及缺铁性贫血病例的结果。区分了高、正常和低体内铁状态。在铁储存疾病和溶血状态下获得的较高范围内的F(v)值,可通过排泄模式进行区分,分别为高F(d)值和低F(ex)值。研究表明,可螯合的体内铁有两个主要来源:作为铁蛋白-含铁血黄素以及以更易螯合的形式从血红素新释放的铁。文中简要讨论了铁代谢中可变螯合敏感性的意义。研究表明,体内不同来源铁的可变螯合性可能解释了在血红素生物合成中优先利用从红细胞释放或从肠道吸收的铁,而非储存铁。

相似文献

1
DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON.
J Clin Pathol. 1965 Jan;18(1):88-97. doi: 10.1136/jcp.18.1.88.
2
Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects.
Br J Haematol. 1979 Aug;42(4):547-55. doi: 10.1111/j.1365-2141.1979.tb01167.x.
3
Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
J Clin Pathol. 1966 Mar;19(2):159-64. doi: 10.1136/jcp.19.2.159.
7
STUDIES ON DESFERRIOXAMINE IN RELATION TO THE ABSORPTION OF IRON.
Br J Haematol. 1965 Jan;11:15-20. doi: 10.1111/j.1365-2141.1965.tb00079.x.
8
THE TREATMENT OF HAEMOCHROMATOSIS WITH DESFERRIOXAMINE.
Acta Haematol. 1963 Aug;30:65-87. doi: 10.1159/000208110.
9
IRON CHELATION WITH DEFEROXAMINE IN HEPATIC DISEASE.
Gastroenterology. 1965 Aug;49:134-40.
10
Desferrioxamine chelatable iron in haemolytic, megaloblastic and sideroblastic anaemias.
Br J Haematol. 1967 Nov;13(6):924-33. doi: 10.1111/j.1365-2141.1967.tb08862.x.

引用本文的文献

1
Recommendations for provoked challenge urine testing.
J Med Toxicol. 2013 Dec;9(4):318-25. doi: 10.1007/s13181-013-0350-7.
2
Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer.
J Neurooncol. 2004 May;67(3):367-77. doi: 10.1023/b:neon.0000024238.21349.37.
4
Cirrhosis with secondary siderosis or primary haemochromatosis.
Proc R Soc Med. 1967 Dec;60(12):1255-7. doi: 10.1177/003591576706001204.
5
Nature of anaemia in rheumatoid arthritis. VII. Storage of iron in rheumatoid disease.
Ann Rheum Dis. 1967 Nov;26(6):552-9. doi: 10.1136/ard.26.6.552.
6
Iron chelation in haematomas at fracture sites.
J Clin Pathol. 1966 Jul;19(4):364-7. doi: 10.1136/jcp.19.4.364.
8
Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
J Clin Pathol. 1966 Mar;19(2):159-64. doi: 10.1136/jcp.19.2.159.
9
Iron overload.
Postgrad Med J. 1969 Mar;45(521):214-9. doi: 10.1136/pgmj.45.521.214.
10
Storage iron depletion in male blood donors: its significance for iron status in women.
J Clin Pathol. 1968 May;21(3):402-5. doi: 10.1136/jcp.21.3.402.

本文引用的文献

1
Effect of Desferrioxamine and D.T.P.A. in Iron Overload.
Br Med J. 1962 Dec 15;2(5319):1573-7. doi: 10.1136/bmj.2.5319.1573.
3
The Iron Reserve of a Normal Man.
J Clin Pathol. 1949 May;2(2):99-102. doi: 10.1136/jcp.2.2.99.
4
Iron metabolism; iron stores in man as measured by phlebotomy.
J Clin Invest. 1952 Jun;31(6):543-7. doi: 10.1172/JCI102639.
7
[Congenital atransferrinemia in a 7-year-old girl].
Dtsch Med Wochenschr. 1961 Sep 15;86:1745-51. doi: 10.1055/s-0028-1113001.
8
Iron metabolism in man.
Ann N Y Acad Sci. 1960 Aug 18;88:460-73. doi: 10.1111/j.1749-6632.1960.tb20043.x.
9
Body iron exchange in man.
J Clin Invest. 1959 Feb;38(2):392-6. doi: 10.1172/JCI103813.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验